Table: begin end state 1 19 cytoplasmic 20 41 transmembrane 42 46 non-cytoplasmic 47 63 transmembrane 64 67 cytoplasmic 68 85 transmembrane 86 90 non-cytoplasmic 91 110 transmembrane 111 117 cytoplasmic 118 138 transmembrane 139 144 non-cytoplasmic 145 164 transmembrane 165 169 cytoplasmic 170 189 transmembrane 190 220 non-cytoplasmic 221 244 transmembrane 245 266 cytoplasmic 267 281 transmembrane 282 292 cytoplasmic 293 311 transmembrane 312 316 non-cytoplasmic 317 337 transmembrane 338 346 cytoplasmic 347 364 transmembrane 365 370 non-cytoplasmic 371 390 transmembrane 391 495 cytoplasmic
Input: >SM_b20070 FitnessBrowser__Smeli:SM_b20070 MKTTITSYKREWFSNIRGDVLSGIVVALALIPEAIGFSVIAGVDPKVGLFASFAIACVSA FAGGRPGMISAATAATAVLMVTLVKEHGLEYLFAATLLMGLFQIAAGFLKLGRVMRFVSR SVITGFVNALAILIFMAQLPELIGVPHLTYAMIAAGLGIIYLFPYVTKAVPSPLVAIAVL TAVDFWTGMDVRTVGDLGALPSSLPIFALPQVPLTFETLQIIFPYSVALAAVGLLESLLT AQIVDDMTDTTSSKSQECIGQGASNIASGLIGGMGGCAMIGQSVINVTSGGRGRLSTFVA GAFLLFLILVLDDLVRIIPMAALVAVMIMVSVGTFSWRSILDLRRNPLPSSVVMLATVVT TVGTHDLAKGVLVGVLLSGVFFAGKVARLFHVRSMLEESGKVRTYHVDGQIFFASTEGFI GAFDFAEPLEKVVIDVGEAHLWDITAVGALDKVVLKYRRHGVTVEVIGLNAASAHMLDRF AVHDKSEGASLTVTH
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server